Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton’s jelly matrix

Cell and Tissue Banking

Volumn 15, Issue 4, 2014, Pages 555-565

  Hendijani, Fatemeh ^a   Sadeghi Aliabadi, Hojjat ^a   Haghjooy Javanmard, Shaghayegh ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Explant culture; Human; Mesenchymal stem cells; Umbilical cord; Wharton s jelly

Indexed keywords

SIGNAL PEPTIDE;

CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; ECONOMICS; HUMAN; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; TIME; TISSUE CULTURE TECHNIQUE; UMBILICAL CORD; WHARTON JELLY;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; COST-BENEFIT ANALYSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; UMBILICAL CORD; WHARTON JELLY;

EID: 84911977722     PISSN: 13899333     EISSN: 15736814     Source Type: Journal    
DOI: 10.1007/s10561-014-9425-1     Document Type: Article

References (40)

1. Atala A, Lanza P (2002) Methods of tissue engineering. Academic Press, San Diego
2. Bordet S, Nguyen TM, Knoppers BM, Isasi R (2010) Use of umbilical cord blood for stem cell research. Journal of Obstetrics and Gynaecology Canada (Journal d’obstetrique et gynecologie du Canada) (JOGC) 32(1):58–61
3. Can A, Karahuseyinoglu S (2007) Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25(11):2886–2895. doi:10.1634/stemcells.2007-0417
4. Carlin R, Davis D, Weiss M, Schultz B, Troyer D (2006) Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 4:8. doi:10.1186/1477-7827-4-8
5. Christodoulou I, Kolisis FN, Papaevangeliou D, Zoumpourlis V (2013) Comparative evaluation of human mesenchymal stem cells of fetal (Wharton’s jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy. Stem Cells Int 2013:246134. doi:10.1155/2013/246134
6. Condic ML, Rao M (2010) Alternative sources of pluripotent stem cells: ethical and scientific issues revisited. Stem Cells Dev 19(8):1121–1129. doi:10.1089/scd 2009.0482
7. Corrao S, La Rocca G, Lo Iacono M, Corsello T, Farina F, Anzalone R (2013) Umbilical cord revisited: from Wharton’s jelly myofibroblasts to mesenchymal stem cells. Histol Histopathol 28(10):1235–44
8. Fan CG, Zhang QJ, Zhou JR (2011) Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7(1):195–207. doi:10.1007/s12015-010-9168-8
9. Fong CY, Richards M, Manasi N, Biswas A, Bongso A (2007) Comparative growth behaviour and characterization of stem cells from human Wharton’s jelly. Reprod Biomed Online 15(6):708–718
10. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A (2010) Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton’s jelly stem cells. Reprod Biomed Online 21(3):391–401. doi:10.1016/j.rbmo.2010.04.010
11. Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A (2011) Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 7(1):1–16. doi:10.1007/s12015-010-9166-x
12. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24(1):115–124. doi:10.1634/stemcells.2005-0053
13. Han YF, Tao R, Sun TJ, Chai JK, Xu G, Liu J (2013) Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology. doi:10.1007/s10616-012-9528-0
14. Hass R, Kasper C, Bohm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (CCS) 9:12. doi:10.1186/1478-811X-9-12
15. Ishige I, Nagamura-Inoue T, Honda MJ, Harnprasopwat R, Kido M, Sugimoto M, Nakauchi H, Tojo A (2009) Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int J Hematol 90(2):261–269
16. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A (2007) Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25(2):319–331. doi:10.1634/stemcells.2006-0286
17. Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ (2011) Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res 346(1):53–64
18. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasa L, Cappello F, Zummo G, Farina F (2009) Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131(2):267–282. doi:10.1007/s00418-008-0519-3
19. Lodi D, Iannitti T, Palmieri B (2011) Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res 30(1):9–28. doi:10.1186/1756-9966-30-9
20. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91(8):1017–1026
21. Majore I, Moretti P, Stahl F, Hass R, Kasper C (2011) Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev 7(1):17–31. doi:10.1007/s12015-010-9165-y
22. Miki T (2011) Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther 2(3):25. doi:10.1186/scrt66
23. Mimeault M, Batra SK (2008) Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev 4(1):27–49. doi:10.1007/s12015-008-9008-2
24. Motaln H, Schichor C, Lah TT (2010) Human mesenchymal stem cells and their use in cell-based therapies. Cancer 116(11):2519–2530. doi:10.1002/cncr.25056
25. O’Brien TA, Tiedemann K, Vowels MR (2006) No longer a biological waste product: umbilical cord blood. Med J Aust 184(8):407–410
26. Otte A, Bucan V, Reimers K, Hass R (2013) Mesenchymal stem cells maintain long-term in vitro stemness during explant culture. Tissue Eng C Methods. doi:10.1089/ten.TEC.2013.0007
27. Petsa A, Gargani S, Felesakis A, Grigoriadis N, Grigoriadis I (2009) Effectiveness of protocol for the isolation of Wharton’s jelly stem cells in large-scale applications. Vitro Cell Dev Biol Anim 45(10):573–576. doi:10.1007/s11626-009-9227-0
28. Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, Jiang R, Yan Y, Mao F, Yang H, Wang X, Chen Y (2008) Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32(1):8–15. doi:10.1016/j.cellbi.2007.08.002
29. Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21(1):105–110. doi:10.1634/stemcells.21-1-105
30. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS, Torshizi Z, Nematollahi-Mahani SN (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. Vitro Cell Dev Biol Anim 48(2):75–83
31. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE (2009) Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 4(8):e6498. doi:10.1371/journal.pone.0006498
32. Seshareddy K, Troyer D, Weiss ML (2008) Method to isolate mesenchymal-like cells from Wharton’s jelly of umbilical cord. Methods Cell Biol 86:101–119
33. Sobolewski K, Malkowski A, Bankowski E, Jaworski S (2005) Wharton’s jelly as a reservoir of peptide growth factors. Placenta 26(10):747–752. doi:10.1016/j.placenta.2004.10.008
34. Taghizadeh RR, Cetrulo KJ, Cetrulo CL (2011) Wharton’s jelly stem cells: future clinical applications. Placenta 32(Suppl. 4):S311–S315
35. Tong CK, Vellasamy S, Tan BC, Abdullah M, Vidyadaran S, Seow HF, Ramasamy R (2011) Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 35(3):221–226. doi:10.1042/CBI20100326
36. Tsagias N, Koliakos I, Karagiannis V, Eleftheriadou M, Koliakos GG (2011) Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfus Med 21(4):253–261. doi:10.1111/j.1365-3148.2011.01076.x
37. Venugopal P, Balasubramanian S, Sen Majumdar A, Ta M (2011) Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions. Stem Cells Cloning Adv Appl 4:39–50. doi:10.2147/SCCAA.S17548
38. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC (2004) Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22(7):1330–1337
39. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D (2006) Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem Cells 24(3):781–792
40. Yoon JH, Roh EY, Shin S, Jung NH, Song EY, Chang JY, Kim BJ, Jeon HY (2013) Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton’s jelly. BioMed Res Int 8 Article ID 428726. doi:10.1155/2013/428726